104586-74-5

Basic information

• Product Name: 3,4-dihydro-9-(3-methoxybenzylamino)acridin-1(2H)-one
• Synonyms: 3,4-dihydro-9-(3-methoxybenzylamino)acridin-1(2H)-one
• CAS NO: 104586-74-5
• Molecular Weight: 332.402
• Mol File: 104586-74-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 3,4-dihydro-9-(3-methoxybenzylamino)acridin-1(2H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: 3,4-dihydro-9-(3-methoxybenzylamino)acridin-1(2H)-one(104586-74-5)
• EPA Substance Registry System: 3,4-dihydro-9-(3-methoxybenzylamino)acridin-1(2H)-one(104586-74-5)

Safety Data

• Hazardous Substances Data: 104586-74-5(Hazardous Substances Data)

Upstream product

• 1885-29-6 anthranilic acid nitrile 
• 104675-23-2 N-(3-oxocyclohexen-1-yl)-2-aminobenzonitrile 
• 504-02-9 1,3-cylohexanedione 
• 104675-26-5 9-Amino-1,2,3,4-tetrahydroacridin-1-one 
• 874-98-6 1-bromomethyl-3-methoxybenzene 

Downstream Products

• 104628-27-5 9-(3-Methoxybenzylamino)-1,2,3,4-tetrahydroacridin-1-ol 

Relevant articles and documents

9-Amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds, a process for their preparation and their use as medicaments

-

9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds

There are disclosed compounds having the formula STR1 wherein n is 1, 2 or 3; X is hydrogen, loweralkyl, loweralkoxy, halogen, hydroxy, nitro, trifluoromethyl, NHCOR2 where R2 is loweralkyl, or NR3 R4 where R3 and R4 are independently hydrogen or loweralkyl; R is hydrogen or loweralkyl; R1 is hydrogen, loweralkyl, diloweralkylaminoloweralkyl, arylloweralkyl, diarylloweralkyl, furylloweralkyl, thienylloweralkyl, oxygen-bridged arylloweralkyl, oxygen-bridged diarylloweralkyl, oxygen-bridged furylloweralkyl or oxygen-bridged thienylloweralkyl; Y is C=O or CR5 OH where R5 is hydrogen or loweralkyl; Z is CH2 or C=CR6 R7 where R6 and R7 are independently hydrogen or loweralkyl; or Y and Z taken together is CR5 =CH where CR5 and CH correspond to Y and Z respectively; an optical antipode thereof, or a pharmaceutically acceptable acid addition salt thereof, which are useful for enhancing memory, methods for synthesizing them, and pharmaceutical compositions comprising an effective memory enhancing amount of such a compound.